These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8713236)

  • 1. Microalbuminuria in non-insulin dependent diabetes and essential hypertension--a marker of severe disease.
    Ahmed S
    J Assoc Physicians India; 1995 Jul; 43(7):517-8. PubMed ID: 8713236
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL; Toto RD; McCullough PA
    J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of microalbuminuria in type 2 diabetes: millimeters or milligrams?
    Glassock RJ
    J Am Soc Nephrol; 2006 Dec; 17(12):3276-8. PubMed ID: 17108313
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of microalbuminuria in type 2 diabetes. BENEDICT study].
    Nitschmann S
    Internist (Berl); 2006 Feb; 47(2):199-200; discussion 200. PubMed ID: 16416298
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R; Mogyorósi A; Ziyadeh FN
    Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension treatment in patients with diabetes].
    Duława J
    Przegl Lek; 1997; 54(11):777-80. PubMed ID: 9501688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slowing progression along the renal disease continuum.
    Kopyt NP
    J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria in non insulin dependent diabetes and essential hypertension: a marker of severe disease.
    Ghai R; Verma NP; Goel A; Bhatnagar MK; Kapoor P; Vashishta A
    J Assoc Physicians India; 1994 Oct; 42(10):771-4. PubMed ID: 7876044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!].
    Dietrich W; Blumenstein M
    MMW Fortschr Med; 2003 Mar; 145(10):40-2. PubMed ID: 12688026
    [No Abstract]   [Full Text] [Related]  

  • 13. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
    Buranakitjaroen P; Deerochanawong C; Bunnag P
    J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating diabetic nephropathy--are there only economic issues?
    Mitch WE
    N Engl J Med; 2004 Nov; 351(19):1934-6. PubMed ID: 15516698
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hypertension in patients with diabetes mellitus.
    Agarwal R
    Indian Heart J; 2001; 53(3):361-9. PubMed ID: 11516043
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microalbuminuria is an early marker for increased morbidity and mortality].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease.
    Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):234-9. PubMed ID: 11881030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.